Tukysa Approved for Unresectable, Metastatic HER2-Positive Breast Cancer

Title: Tukysa Approved for Unresectable, Metastatic HER2-Positive Breast CancerCategory: Health NewsCreated: 4/20/2020 12:00:00 AMLast Editorial Review: 4/21/2020 12:00:00 AM

http://www.medicinenet.com/script/main/art.asp?articlekey=230546

Source: MedicineNet Cancer General - April 21, 2020 Category: Cancer & Oncology Source Type: news

More News: Breast Cancer | Cancer | Cancer & Oncology | HER2